ECS Botanics Holdings Ltd represents a dedication to sustainable and high-quality botanical products. As a company, ECS Botanics aims to provide value to its stakeholders, including customers and shareholders, by prioritizing ethical and environmentally conscious practices. Their corporate philosophy encompasses a commitment to research and innovation, ensuring the development of products that meet the evolving needs of consumers. By staying true to their values, ECS Botanics Holdings Ltd strives to establish itself as a leading player in the industry, offering trusted and reliable botanical solutions to individuals and businesses alike.

ECS Botanics Holdings Ltd is primarily present in Australia.

ECS Botanics Holdings Ltd has achieved several significant milestones. The company successfully listed on the Australian Securities Exchange (ASX) in 2020, marking a major achievement in its growth trajectory. Furthermore, ECS Botanics expanded its operations by acquiring Murray Meds, a licensed medicinal cannabis producer in Australia, strengthening its foothold in the industry. With a focus on sustainable farming practices, ECS Botanics has established itself as a leading player in the Australian cannabis market. The company's commitment to high-quality products and strategic partnerships with reputable brands has also contributed to its ongoing success and market recognition.

ECS Botanics Holdings Ltd is an Australian company specializing in the cultivation and production of medicinal cannabis. With a rich history and background, ECS Botanics Holdings Ltd was established in 2004. The company has positioned itself as a leading player in the Australian cannabis industry, leveraging its expertise in sustainable farming practices and cannabinoid extraction. With a strong focus on quality and innovation, ECS Botanics Holdings Ltd aims to deliver premium cannabis products to meet the growing demands of patients and consumers. As a vertically integrated company, it controls the entire production process, from seed to sale, ensuring the highest standards are met.

The main competitors of ECS Botanics Holdings Ltd in the market include other leading players in the cannabis industry such as Canopy Growth Corporation, Aurora Cannabis Inc., and Tilray Inc. These companies also operate in the cultivation, production, and distribution of cannabis products, creating a competitive landscape for ECS Botanics Holdings Ltd.

ECS Botanics Holdings Ltd primarily operates in the industries of agriculture, manufacturing, and distribution of hemp-based products. The company specializes in the cultivation, processing, and sale of medicinal cannabis and hemp derivatives. With a focus on sustainable and organic practices, ECS Botanics Holdings Ltd is dedicated to providing high-quality hemp-derived products for various applications, including health and wellness, cosmetics, and food and beverage industries. As a leading player in the hemp industry, ECS Botanics Holdings Ltd is committed to delivering innovative and environmentally friendly solutions to meet the growing global demand for CBD and hemp-related products.

The business model of ECS Botanics Holdings Ltd focuses on cultivating and producing high-quality medicinal cannabis and hemp products. ECS Botanics is committed to sustainable and organic farming practices to ensure the purity and efficacy of their products. With a vertically integrated approach, they control the entire supply chain, from seed to sale, allowing for full traceability and quality control. ECS Botanics aims to meet the growing demand for natural health and wellness products derived from cannabis and hemp, offering consumers a wide range of therapeutic options.

The ECS Botanics Holdings P/E ratio is 9.54.

The ECS Botanics Holdings P/S ratio is 0.89.

The Quality Investing for ECS Botanics Holdings is 2/10.

The ECS Botanics Holdings revenue is 20.5 M AUD.

The ECS Botanics Holdings profit is 1.92 M AUD.

ECS Botanics Holdings Ltd is an Australian company that specializes in the production and sale of hemp-based products. The company's business model focuses on capitalizing on the growing consumer interest in natural health and wellness products. At the core of ECS Botanics Holdings Ltd's business model is the production of high-quality CBD oil from hemp. The company cultivates its own specific hemp strains to ensure the potency and purity of its CBD products. ECS Botanics Holdings Ltd utilizes sustainable farming methods to minimize environmental impact. The company operates in various sectors including the production of CBD oils, herbal extracts, and superfoods. ECS Botanics Holdings Ltd also offers processed hemp products such as food, skincare products, and pet food. These products are all designed for the growing market of natural products, providing customers with a wide range of options. To bring its products to consumers, ECS Botanics Holdings Ltd has established various distribution channels including online sales platforms and retail outlets. The company also collaborates directly with retailers to sell its products in their stores. ECS Botanics Holdings Ltd has also built international partnerships to distribute its products globally. ECS Botanics Holdings Ltd is dedicated to the quality and effectiveness of its products. The manufacturing process undergoes strict quality controls to ensure consistent product quality. The company also conducts regular testing to ensure its products meet applicable standards. The company has also formed partnerships with universities and research institutions to investigate the effectiveness of hemp products in health research. This will help develop innovative products that benefit customers. Overall, ECS Botanics Holdings Ltd's business model offers a wide range of natural products tailored to the consumer demand for natural health and wellness products. Through the use of sustainable farming methods and strict quality controls, the company provides high-quality products that meet customer needs. With its various distribution channels and partnerships, ECS Botanics Holdings Ltd has been able to increase its presence in different markets and establish its brand worldwide.

ECS Botanics Holdings pays a dividend of 0 AUD distributed over payouts per year.

The dividend cannot currently be calculated for ECS Botanics Holdings or the company does not pay out a dividend.

The ISIN of ECS Botanics Holdings is AU0000052490.

The WKN of ECS Botanics Holdings is A2PN00.

The ticker of ECS Botanics Holdings is ECS.AX.

Over the past 12 months, ECS Botanics Holdings paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ECS Botanics Holdings is expected to pay a dividend of 0 AUD.

The current dividend yield of ECS Botanics Holdings is .

ECS Botanics Holdings pays a quarterly dividend. This is distributed in the months of .

ECS Botanics Holdings paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

ECS Botanics Holdings is assigned to the 'Health' sector.

To receive the latest dividend of ECS Botanics Holdings from 11/8/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.

The last dividend was paid out on 11/8/2024.

In the year 2023, ECS Botanics Holdings distributed 0 AUD as dividends.

The dividends of ECS Botanics Holdings are distributed in AUD.